PI Post Acute Access Act

This bill amends Medicare coverage under the Social Security Act to specifically include "items and services needed for the administration of intravenous immune globulin for the treatment of primary immune deficiency disease" in skilled nursing facilities. It directly affects Medicare beneficiaries with primary immunodeficiency diseases who require IV immune globulin treatments in post-acute care settings. The key change adds this specific treatment to Medicare's covered services, ensuring reimbursement for these necessary care components. The amendment takes effect for services provided on or after January 1, 2024.